The Assessment on Synergistic Activity of Ebselen and Silver Ion Against Yersinia pseudotuberculosis
- PMID: 35958130
- PMCID: PMC9363147
- DOI: 10.3389/fmicb.2022.963901
The Assessment on Synergistic Activity of Ebselen and Silver Ion Against Yersinia pseudotuberculosis
Abstract
Yersinia pseudotuberculosis is a foodborne zoonotic bacterium that is pathogenic to guinea pigs, rabbits, and mice. It also causes pseudotuberculosis in humans. However, it still lacked the scientific basis for control. Here, we found out that Ebselen (EbSe) exhibited synergistic antibacterial activity with silver nitrate (Ag+) against Y. pseudotuberculosis YpIII strain with high efficacy in vitro using UV-visible light absorption spectrum, 5,5'-dithiobis-(2-nitrobenzoic acid), laser scanning confocal microscope, flow cytometry, transmission electron microscopy and Western blotting assays. The depletion of total glutathione (GSH) amount and inhibition of thioredoxin reductase (TrxR) activity in thiol-dependent redox system revealed the destructiveness of EbSe-Ag+-caused intracellular oxidative stress. Furthermore, a YpIII-caused mice gastroenteritis model was constructed. EbSe-Ag+ significantly reduced bacterial loads with low toxicity. It also down-regulated the expression levels of interferon (IL)-1β and tumor necrosis factor-α, up-regulated the expression level of IL-10 on-site. All the in vivo results demonstrated the antibacterial activity and immune-modulatory property of EbSe-Ag+. Collectively, these results provided academic fundament for further analysis and development of EbSe-Ag+ as the antibacterial agents for pseudotuberculosis control.
Keywords: Ebselen; Yersinia pseudotuberculosis; antibacterial activity; immune-modulatory property; silver nitrate.
Copyright © 2022 Dong, Chen, Zou, Liu, Deng, Guo, Wang, Chen, Wang and Wang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures












Similar articles
-
Enhance the Antimycobacterial Activity of Streptomycin with Ebselen as an Antibiotic Adjuvant Through Disrupting Redox Homeostasis.Drug Des Devel Ther. 2024 Aug 27;18:3811-3824. doi: 10.2147/DDDT.S475535. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 39219694 Free PMC article.
-
Synergistic therapeutic efficacy of ebselen and silver ions against multidrug-resistant Acinetobacter baumannii-induced urinary tract infections.Metallomics. 2020 Jun 24;12(6):860-867. doi: 10.1039/d0mt00091d. Metallomics. 2020. PMID: 32452501
-
Depletion of multidrug-resistant uropathogenic Escherichia coli BC1 by ebselen and silver ion.J Cell Mol Med. 2020 Nov;24(22):13139-13150. doi: 10.1111/jcmm.15920. Epub 2020 Sep 25. J Cell Mol Med. 2020. PMID: 32975381 Free PMC article.
-
Characterization of synergistic antibacterial effect of silver nanoparticles and ebselen.Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):3338-3349. doi: 10.1080/21691401.2019.1648278. Artif Cells Nanomed Biotechnol. 2019. PMID: 31387398
-
Selenocysteine in mammalian thioredoxin reductase and application of ebselen as a therapeutic.Free Radic Biol Med. 2018 Nov 1;127:238-247. doi: 10.1016/j.freeradbiomed.2018.05.081. Epub 2018 May 25. Free Radic Biol Med. 2018. PMID: 29807162 Review.
Cited by
-
Antibacterial Activity of Ebselen.Int J Mol Sci. 2023 Jan 13;24(2):1610. doi: 10.3390/ijms24021610. Int J Mol Sci. 2023. PMID: 36675123 Free PMC article. Review.
-
The synergistic activity of SBC3 in combination with Ebselen against Escherichia coli infection.Front Pharmacol. 2022 Dec 15;13:1080281. doi: 10.3389/fphar.2022.1080281. eCollection 2022. Front Pharmacol. 2022. PMID: 36588729 Free PMC article.
-
Ebselen: A Promising Repurposing Drug to Treat Infections Caused by Multidrug-Resistant Microorganisms.Interdiscip Perspect Infect Dis. 2024 Mar 30;2024:9109041. doi: 10.1155/2024/9109041. eCollection 2024. Interdiscip Perspect Infect Dis. 2024. PMID: 38586592 Free PMC article. Review.
-
Disruption of Bacterial Thiol-Dependent Redox Homeostasis by Magnolol and Honokiol as an Antibacterial Strategy.Antioxidants (Basel). 2023 May 30;12(6):1180. doi: 10.3390/antiox12061180. Antioxidants (Basel). 2023. PMID: 37371909 Free PMC article.
-
Enhance the Antimycobacterial Activity of Streptomycin with Ebselen as an Antibiotic Adjuvant Through Disrupting Redox Homeostasis.Drug Des Devel Ther. 2024 Aug 27;18:3811-3824. doi: 10.2147/DDDT.S475535. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 39219694 Free PMC article.
References
-
- Bakholdina S. I., Shubin F. N., Solov’eva T. F. (2009). [Oxygen deficiency increases invasive activity and resistance of Yersinia pseudotuberculosis to heat stress]. Zh. Mikrobiol. Epidemiol. Immunobiol. 3 18–23. - PubMed
LinkOut - more resources
Full Text Sources